K. Mayer

发表

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

M. Fischer, H. Schunkert, A. Kastrati, 2017, Thrombosis and Haemostasis.

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

W. Rottbauer, M. Fischer, H. Schunkert, 2019, The New England journal of medicine.

No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2011, European heart journal.

Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI—Design and Rationale of the Randomized ISAR-PLASTER Trial

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Thrombosis and Haemostasis.

Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction

M. Hadamitzky, J. Hausleiter, H. Schunkert, 2014, Thrombosis and Haemostasis.

Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting

A. Kastrati, A. Schömig, D. Sibbing, 2013, Thrombosis and Haemostasis.

Predictors of antiplatelet response to prasugrel during maintenance treatment

M. Hadamitzky, H. Schunkert, A. Kastrati, 2015, Platelets.

Antithrombotic therapy with or without aspirin after percutaneous coronary intervention or acute coronary syndrome in patients taking oral anticoagulation: A meta-analysis and network analysis of randomized controlled trials.

A. Kastrati, G. Ndrepepa, K. Mayer, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study

A. Kastrati, D. Sibbing, K. Mayer, 2016, Platelets.

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.

H. Schunkert, A. Kastrati, B. Haller, 2015, European heart journal.

Randomized Comparison of Intensified and Standard P2Y12-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention

A. Kastrati, J. Mehilli, F. Neumann, 2020, Circulation. Cardiovascular interventions.

Prognostic Value of High-sensitivity Troponin T After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Revista espanola de cardiologia.

Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST‐Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Clinical cardiology.

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.

H. Schunkert, A. Kastrati, A. Hapfelmeier, 2021, JAMA cardiology.

Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis

M. Fischer, H. Schunkert, A. Kastrati, 2016, Scientific Reports.

Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial

H. Schunkert, A. Kastrati, F. Neumann, 2014, Journal of Cardiovascular Translational Research.

Prognostic value of haemoglobin drop in patients with acute coronary syndromes

H. Schunkert, M. Joner, A. Kastrati, 2021, European journal of clinical investigation.

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.

J. Erdmann, H. Schunkert, N. Eriksson, 2019, Cardiovascular research.

Sex differences in the outcome after percutaneous coronary intervention - A propensity matching analysis.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

H. Schunkert, M. Joner, A. Kastrati, 2020, Circulation.

One-Year Ischemic and Bleeding Events According to Renal Function in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Third-Generation Antiplatelet Drugs.

A. Kastrati, G. Ndrepepa, K. Mayer, 2022, The American journal of cardiology.

Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2020, Journal of the American College of Cardiology.

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes

H. Schunkert, A. Kastrati, F. Neumann, 2020, Annals of Internal Medicine.

High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring

A. Kastrati, A. Schömig, D. Sibbing, 2013, Platelets.

Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2021, Revista espanola de cardiologia.

Relation of Ratio of Left Ventricular Ejection Fraction to Left Ventricular End-Diastolic Pressure to Long-Term Prognosis After ST-Segment Elevation Acute Myocardial Infarction.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, The American journal of cardiology.

Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial

H. Schunkert, A. Kastrati, F. Neumann, 2021, Journal of atherosclerosis and thrombosis.

Increased bleeding risk during percutaneous coronary interventions by arterial hypertension

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention

H. Schunkert, M. Joner, A. Kastrati, 2021, Circulation. Cardiovascular interventions.

Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women: Gender-Based Analysis of a Large Scale, Randomized Clinical Trial

H. Schunkert, A. Kastrati, I. Ott, 2018, Circulation. Cardiovascular interventions.

A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity

H. Schunkert, A. Kastrati, J. Hausleiter, 2014, Thrombosis and Haemostasis.

Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial.

H. Schunkert, A. Kastrati, D. Angiolillo, 2020, Journal of the American College of Cardiology.

Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis.

R. Schermuly, C. Hamm, K. Mayer, 2012, European heart journal.

Does Size Matter?: In Search of a Physiological Definition of Myocardial Atrophy

H. Schunkert, A. Kastrati, D. Sibbing, 2017 .

Outcome after new generation single‐layer polytetrafluoroethylene‐covered stent implantation for the treatment of coronary artery perforation

A. Kastrati, K. Mayer, S. Kufner, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Circulation: Cardiovascular Interventions

H. Schunkert, M. Joner, A. Kastrati, 2022 .

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Journal of the American Heart Association.

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

H. Schunkert, M. Joner, A. Kastrati, 2022, Thrombosis and Haemostasis.

Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.

A. Kastrati, J. Mehilli, D. Sibbing, 2013, Journal of the American College of Cardiology.

Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)

A. Kastrati, J. Mehilli, D. Sibbing, 2015, BioMed research international.

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

H. Schunkert, M. Joner, A. Kastrati, 2021, Journal of the American Heart Association.

Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions

L. Räber, A. Kastrati, S. Windecker, 2018, Circulation. Cardiovascular interventions.

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry

H. Schunkert, A. Kastrati, G. Ndrepepa, 2023, Clinical Research in Cardiology.

Immature platelet fraction is a strong predictor of adverse cardiovascular events in patients with acute coronary syndrome. Results of the ISAR-REACT 5 reticulated platelet substudy

H. Schunkert, A. Kastrati, K. Mayer, 2020 .

Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial.

H. Schunkert, M. Joner, A. Kastrati, 2021, European heart journal. Acute cardiovascular care.

The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry.

M. Hadamitzky, H. Schunkert, A. Kastrati, 2015, Thrombosis research.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus.

H. Schunkert, A. Kastrati, F. Neumann, 2020, JACC. Cardiovascular interventions.

TCT-207 Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents.

A. Kastrati, Y. Harada, J. Michel, 2016, Journal of the American College of Cardiology.

Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER Trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Circulation. Cardiovascular interventions.

Platelet hyperreactivity and stent thrombosis in patients undergoing coronary stenting.

D. Sibbing, K. Mayer, 2012, Current vascular pharmacology.

Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation

H. Schunkert, M. Joner, A. Kastrati, 2022, Circulation. Cardiovascular interventions.

The role of surface electrocardiogram after complex left atrial arrhythmias' ablation: behind electrical mechanisms.

K. Mayer, T. Reents, A. Buiatti, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry.

H. Schunkert, A. Kastrati, D. Sibbing, 2014, Journal of the American College of Cardiology.

ADP-induced platelet aggregation in patients with acute coronary syndrome treated with prasugrel or ticagrelor. Results of the ISAR REACT 5 platelet aggregation substudy

H. Schunkert, A. Kastrati, K. Mayer, 2020 .

10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents.

H. Schunkert, M. Joner, A. Kastrati, 2020, Journal of the American College of Cardiology.

Prognostic value of thyroid-stimulating hormone within reference range in patients with coronary artery disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2015, Metabolism: clinical and experimental.

Efficacy of drug‐coated balloon angioplasty in early versus late occurring drug‐eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials

A. Kastrati, K. Mayer, R. Tölg, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate.

H. Schunkert, M. Joner, A. Kastrati, 2021, JACC: Cardiovascular Interventions.

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial

H. Schunkert, M. Joner, A. Kastrati, 2019, Circulation.

Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy

H. Schunkert, A. Kastrati, D. Angiolillo, 2022, Arteriosclerosis, thrombosis, and vascular biology.

Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.

H. Schunkert, M. Joner, A. Kastrati, 2021, JAMA cardiology.

Reply: Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry.

H. Schunkert, A. Kastrati, D. Sibbing, 2015, Journal of the American College of Cardiology.

Comparison of the FemoSeal Vascular Closure Device With Manual Compression After Femoral Artery Puncture - Post-hoc Analysis of a Large-Scale, Randomized Clinical Trial.

H. Schunkert, A. Kastrati, K. Mayer, 2018, The Journal of invasive cardiology.

EMMPRIN (CD147/basigin) mediates platelet–monocyte interactions in vivo and augments monocyte recruitment to the vascular wall

E. Kremmer, P. Cullen, B. Nieswandt, 2011, Journal of thrombosis and haemostasis : JTH.

No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2011, European heart journal.

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Clinical cardiology.

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.

H. Schunkert, A. Kastrati, B. Haller, 2015, European heart journal.

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

M. Fischer, H. Schunkert, A. Kastrati, 2017, Thrombosis and Haemostasis.

Very long-term outlook of acute coronary syndromes after percutaneous coronary intervention with implantation of polymer-free versus durable-polymer new-generation drug-eluting stents.

H. Schunkert, M. Joner, A. Kastrati, 2023, Minerva medica.

Body mass index and efﬁcacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes

G. Ndrepepa, D. Angiolillo, D. Sibbing, 2022 .

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation.

H. Schunkert, A. Kastrati, J. Mehilli, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.